US 10,888,601 K2 (3,963rd)
	Use of a VEGF antagonist to treat angiogenic eye disorders
George D. Yancopoulos
Assigned to REGENERON PHARMACEUTICALS, INC.
Trial No. IPR2023-00739, Mar. 26, 2023
Trial No. IPR2024-00201, Nov. 20, 2023
Inter Partes Review Certificate for Patent 10,888,601, issued Jan. 12, 2021, Appl. No. 16/397,267, Apr. 29, 2019
Inter Partes Review Certificate issued Apr. 21, 2025